THLAI

Arunraj Dhamodaran1,2,3, Xiaojing Chen1, Niklas Fellmer2

  • 1Molecular Immunology and Gene Therapy, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

PubMed
概括

新的ABab-I小鼠表达了多个人类白细胞抗原I类基因,增强了用于癌症免疫治疗的T细胞受体发现. 这些小鼠提供更广泛的HLA覆盖范围,可能扩大患者对T细胞受体治疗的资格.